Global Health Limited
Symboli: MEDANTA.NS
NSE
1407
INRMarkkinahinta tänään
83.0259
P/E-suhde
0.0000
PEG-suhde
377.79B
MRK Cap
- 0.00%
DIV Tuotto
Global Health Limited (MEDANTA-NS) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13107.8 | 5118.1 | 2893 | |||||
balance-sheet.row.short-term-investments | 0 | 5435.4 | 3923.8 | 2198.3 | |||||
balance-sheet.row.net-receivables | 0 | 1942 | 2423.8 | 1655 | |||||
balance-sheet.row.inventory | 0 | 603.7 | 533.9 | 397.6 | |||||
balance-sheet.row.other-current-assets | 0 | 141.3 | 41.5 | 1730.7 | |||||
balance-sheet.row.total-current-assets | 0 | 15794.9 | 8117.2 | 5021.3 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 23719 | 22088.5 | 20722.4 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.long-term-investments | 0 | -5005.5 | -3818.9 | -2009.8 | |||||
balance-sheet.row.tax-assets | 0 | 257.1 | 277.9 | 257.4 | |||||
balance-sheet.row.other-non-current-assets | 0 | 6342.6 | 4727.8 | 2877.2 | |||||
balance-sheet.row.total-non-current-assets | 0 | 25364.8 | 23337.9 | 21919.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.account-payables | 0 | 1946.9 | 1343.3 | 1315.5 | |||||
balance-sheet.row.short-term-debt | 0 | 1393.6 | 1055.9 | 1029.5 | |||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.long-term-debt-total | 0 | 9825.9 | 10033.3 | 8284.2 | |||||
Deferred Revenue Non Current | 0 | 669.7 | 218.7 | 363.4 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 983.5 | 23.7 | 14.1 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 11152 | 11100.3 | 9071 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 2797.3 | 2710.6 | 2867.8 | |||||
balance-sheet.row.total-liab | 0 | 16877.6 | 15295.1 | 13117.6 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 325 | |||||
balance-sheet.row.common-stock | 0 | 536.4 | 506.4 | 820.9 | |||||
balance-sheet.row.retained-earnings | 0 | 12837.9 | 9529.6 | 7689.8 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 237.3 | 274.5 | 442.5 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 10670.5 | 5849.6 | 4545.2 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 429.9 | 104.9 | 188.6 | |||||
balance-sheet.row.total-debt | 0 | 11219.5 | 11089.3 | 9313.8 | |||||
balance-sheet.row.net-debt | 0 | 3547.1 | 9894.9 | 8619.1 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4492.9 | 2805.6 | 324.6 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
cash-flows.row.deferred-income-tax | 0 | -7.5 | -874.5 | 131.7 | |||||
cash-flows.row.stock-based-compensation | 0 | 7.5 | 17.4 | 37.9 | |||||
cash-flows.row.change-in-working-capital | 0 | 1028.2 | -667.7 | 365.9 | |||||
cash-flows.row.account-receivables | 0 | -214.6 | -495.6 | 102.9 | |||||
cash-flows.row.inventory | 0 | -69.8 | -136.3 | -12.4 | |||||
cash-flows.row.account-payables | 0 | 603.6 | 27.8 | 8.1 | |||||
cash-flows.row.other-working-capital | 0 | 709 | -63.5 | 267.4 | |||||
cash-flows.row.other-non-cash-items | 0 | -582.6 | 534.7 | 325.4 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.acquisitions-net | 0 | 8 | 13.8 | 38 | |||||
cash-flows.row.purchases-of-investments | 0 | -1416.1 | -1725.4 | -1172.8 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | -8 | 83.7 | 50.4 | |||||
cash-flows.row.other-investing-activites | 0 | 352.5 | 163.8 | 150.3 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3423.4 | -4208.9 | -2391.5 | |||||
cash-flows.row.debt-repayment | 0 | -666.5 | -198.9 | -30.2 | |||||
cash-flows.row.common-stock-issued | 0 | 4785.5 | 379.5 | 2.4 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | -662.6 | 1415.2 | -779.4 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3456.4 | 1595.9 | -807.2 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | 6478.1 | 499.7 | -781 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 7672.4 | 1194.3 | 694.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1194.3 | 694.7 | 1475.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 6445.2 | 3112.6 | 2417.7 | |||||
cash-flows.row.capital-expenditure | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.free-cash-flow | 0 | 4085.3 | 367.9 | 960.3 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 26942.5 | 21559.7 | 14306.1 | |||||
income-statement-row.row.cost-of-revenue | 0 | 6252.8 | 5429.3 | 3485.6 | |||||
income-statement-row.row.gross-profit | 0 | 20689.6 | 16130.4 | 10820.6 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.operating-expenses | 0 | 15990.5 | 12730.5 | 9893.6 | |||||
income-statement-row.row.cost-and-expenses | 0 | 22243.3 | 18159.8 | 13379.2 | |||||
income-statement-row.row.interest-income | 0 | 346.2 | 167.2 | 177.6 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.total-operating-expenses | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 5348.3 | 3399.9 | 927 | |||||
income-statement-row.row.income-before-tax | 0 | 4492.9 | 2805.6 | 324.6 | |||||
income-statement-row.row.income-tax-expense | 0 | 1232.1 | 843.6 | 36.6 | |||||
income-statement-row.row.net-income | 0 | 3260.8 | 1962 | 288.1 |
Usein kysytty kysymys
Mikä on Global Health Limited (MEDANTA.NS) taseen loppusumma?
Global Health Limited (MEDANTA.NS) kokonaisvarat ovat 41159640000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.768.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 12.311.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.143.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.226.
Mikä on Global Health Limited (MEDANTA.NS) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 3260793000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 11219519000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 15990499000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.